| abstract |
The present invention relates to a cycloalkenyl aryl derivative or an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, a preparation method thereof, and a pharmaceutical composition containing the same as an active ingredient. In addition, the compounds of formula (I) of the present invention have a CETP inhibitory effect, which raises HDL-cholesterol and reduces LDL-cholesterol. [Formula 1] |